Skip to content
10-Q

Quarterly Report

BIOATLA, INC. BCAB

0001193125-25-280435

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q3 2025 · Sep 30, 2025 58.75M sh
Shares Diluted Q3 2025 · Sep 30, 2025 58.5M sh
Shares Diluted Q3 2025 · Sep 30, 2024 48.34M sh
Shares Diluted Q3 2025 · Sep 30, 2024 48.21M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$40.29M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$55.15M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $8.32M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $49.05M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$31.24M
Stockholders Equity Q3 2025 · Dec 31, 2024 $14.27M
Current Liabilities Q3 2025 · Sep 30, 2025 $17.98M
Current Liabilities Q3 2025 · Dec 31, 2024 $14.54M
Total Liabilities Q3 2025 · Sep 30, 2025 $47.15M
Total Liabilities Q3 2025 · Dec 31, 2024 $38.16M
Current Assets Q3 2025 · Sep 30, 2025 $9.67M
Current Assets Q3 2025 · Dec 31, 2024 $51.23M
Total Assets Q3 2025 · Sep 30, 2025 $15.91M
Total Assets Q3 2025 · Dec 31, 2024 $52.42M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.27
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.85
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.22
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.14
Eps Basic Q3 2025 · Sep 30, 2025 −$0.27
Eps Basic Q3 2025 · Sep 30, 2025 −$0.85
Eps Basic Q3 2025 · Sep 30, 2024 −$0.22
Eps Basic Q3 2025 · Sep 30, 2024 −$1.14
Sga Expense Q3 2025 · Sep 30, 2025 $4.25M
Sga Expense Q3 2025 · Sep 30, 2025 $14.47M
Sga Expense Q3 2025 · Sep 30, 2024 $5.88M
Sga Expense Q3 2025 · Sep 30, 2024 $17.25M
Rd Expense Q3 2025 · Sep 30, 2025 $9.54M
Rd Expense Q3 2025 · Sep 30, 2025 $35.58M
Rd Expense Q3 2025 · Sep 30, 2024 $16.4M
Rd Expense Q3 2025 · Sep 30, 2024 $51.45M
Net Income Q3 2025 · Sep 30, 2025 −$15.78M
Net Income Q3 2025 · Sep 30, 2025 −$49.82M
Net Income Q3 2025 · Sep 30, 2024 −$10.59M
Net Income Q3 2025 · Sep 30, 2024 −$54.89M
Operating Income Q3 2025 · Sep 30, 2025 −$13.79M
Operating Income Q3 2025 · Sep 30, 2025 −$50.05M
Operating Income Q3 2025 · Sep 30, 2024 −$11.27M
Operating Income Q3 2025 · Sep 30, 2024 −$57.7M